在食道状细胞癌中,表皮-介质细胞转化和 Cisplatin 耐药性背后的分子机制
相关实验视频
Updated: Jul 16, 2025

10:43
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
3.4K
Kewei Song1,2, Chenhui Ma1, Baohong Gu1
1The Second Clinical Medical College, Lanzhou University, Lanzhou, China.
Thoracic cancer
|September 18, 2023
概括
食道状细胞癌 (ESCC) 常常会对西斯 (DDP) 化疗产生耐药性. 本综述探讨了表皮-介质细胞转化 (EMT) 如何对这种耐药性作出贡献,为新的治疗策略提供了见解.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 食道癌 (EC) 是全球癌症死亡的主要原因.
- 食道状细胞癌 (ESCC) 是最常见的EC类型.
- 西斯 (DDP) 是高级ESCC的主要化疗法,但耐药性是临床的主要挑战.
研究的目的:
- 阐明ESCC的分子机制.
- 研究ESCC中DDP抗性的机制.
- 探索表皮-介质细胞转化 (EMT) 和ESCC化学抵抗之间的相互作用.
主要方法:
- 对ESCC分子机制的当前文献的综述.
- 对研究DDP耐药性途径的研究进行分析.
- 检查ESCC中将EMT与化疗耐药性联系在一起的研究.
主要成果:
- EMT是与瘤细胞中化学抵抗相关的关键过程.
- 在EMT和ESCC的发展之间存在相互关系.
- 了解EMT-ESCC的相互作用对于克服DDP阻力至关重要.
结论:
- 在食道状细胞癌中,EMT在产生西斯普拉丁耐药性方面发挥着重要作用.
- 针对EMT途径可能为ESCC提供新的治疗策略.
- 对EMT-ESCC相互作用的进一步研究可能会导致改善患者的治疗结果.
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K

